Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02991430 · ClinicalTrials.gov registry record · NA
A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache
A NA study, sponsored by Scion NeuroStim.
- Terminated
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT02991430: Clinical Trial NA study, sponsored by Scion NeuroStim.
NCT02991430 is a NA study that was terminated before completion, run by Scion NeuroStim. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02991430, a NA study, was terminated before completion, sponsored by Scion NeuroStim.
- TERMINATED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
This study will assess the efficacy of a neuromodulation device for the treatment of episodic migraine headache.
Primary Outcome
comparison of MHD recorded in baseline month versus 3rd month of treatment
Interventions
- DEVICE active neuromodulation for episodic migraine headache
- DEVICE placebo neuromodulation for episodic migraine headache
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2017-06-30 |
| Est. Completion | 2018-05-11 |
| Phase | NA |
Why NCT02991430 stopped before completion
NCT02991430 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which active neuromodulation for episodic migraine headache is the first listed.
NCT02991430 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02991430 about?
NCT02991430 is a clinical study titled "A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache". This study will assess the efficacy of a neuromodulation device for the treatment of episodic migraine headache.
What is the current status of trial NCT02991430?
This trial is currently terminated. It is a NA study. The enrollment target is 45 participants. The study started on 2017-06-30. Estimated completion is 2018-05-11.
What interventions are being tested in trial NCT02991430?
The interventions under investigation include: active neuromodulation for episodic migraine headache (DEVICE), placebo neuromodulation for episodic migraine headache (DEVICE).
Who is sponsoring clinical trial NCT02991430?
This trial is sponsored by Scion NeuroStim, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02991430's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI